Di Maio, M., G. Daniele, and M.C. Piccirillo. “Impact on Health-Related Quality of Life of the Addition of Bevacizumab to First-Line Chemotherapy for Ovarian Cancer:  ”. Cancer Breaking News 1, no. 1 (October 15, 2013): 33–35. Accessed July 3, 2024. https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/254.